课题基金 / 基金详情

Atypical bovine morbillivirus infections in the Serengeti ecosystem

Atypical bovine morbillivirus infections in the Serengeti ecosystem
塞伦盖蒂生态系统中的非典型牛麻疹病毒感染
批准号:
BB/R004250/1
负责人:
Brian Willett
金额:
$61.88万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --

项目摘要

项目成果

Brian Willett的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Once the scourge of European, African and Asian livestock and wild ruminants, rinderpest virus is only the second virus in history after smallpox to be eradicated globally by vaccination. Rinderpest virus (RPV) is a morbillivirus, a close relative of measles virus (MV). Rinderpest was a devastating disease, threatening both food security and the health and wellbeing of many of the poorest livestock-dependent communities in the world. The eradication of rinderpest was arguably one of the most significant global successes in veterinary medicine. In recent years, we have developed highly sensitive and specific diagnostic tests with which we can measure morbillivirus-specific neutralising antibodies. Using these tests, we have identified sera from cattle in Northern Tanzania that display specific neutralising activity against novel cattle morbilliviruses, including canine distemper virus (CDV), peste des petits ruminants virus (PPRV) and a rinderpest-related bovine morbillivirus. The aim of this project is to characterise novel and atypical bovine morbilliviruses circulating in Northern Tanzania. We will build upon our preliminary screening of cattle sera, focussing on a set of ~5000 cattle sera from neighbouring areas of Serengeti and Ngorongoro districts. Collected between 2010 and 2016, these sera will provide a snapshot of the prevalence of morbillivirus-specific antibodies across the region and will enable us to locate target sites for future field studies. Informed by our findings, we will collect fresh sample material from herds in villages known to harbour antibody-positive animals, generating material for virus characterisation as well as allowing assessment of their clinical significance. The samples will be screened to identify the animals with morbillivirus-specific antibodies and the corresponding blood samples and swabs screened for viral gene sequences. These analyses will reveal the origin of the antibody reactivity, the nature of the infective agent and will permit the design of a more effective diagnostic test for the virus(es).This project will provide epidemiological and biological data to evaluate the potential threat posed by morbilliviruses in cattle. It will generate assay systems with which the viruses may be detected and inform strategies for subsequent monitoring and control. The knowledge generated by this project will counter the risk of a novel morbillivirus emerging in cattle, ensure that immunosurveillance for morbilliviruses is not undermined by misdiagnosis, while facilitating the design of future campaigns for control and eradication by vaccination.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1093/ve/veab062
发表时间: 2021
期刊: Virus evolution
影响因子: 5.3
作者: [Benfield CTO, Hill S, Shatar M, Shiilegdamba E, Damdinjav B, Fine A, Willett B, Kock R, Bataille A]
通讯作者: Bataille A
DOI: 10.1101/2021.09.15.459147
发表时间: 2021
期刊:
影响因子: --
作者: [De Glanville W]
通讯作者: De Glanville W
DOI: 10.1073/pnas.2000153117
发表时间: 2020-12-15
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Gilbert M, Sulikhan N, Uphyrkina O, Goncharuk M, Kerley L, Castro EH, Reeve R, Seimon T, McAloose D, Seryodkin IV, Naidenko SV, Davis CA, Wilkie GS, Vattipally SB, Adamson WE, Hinds C, Thomson EC, Willett BJ, Hosie MJ, Logan N, McDonald M, Ossiboff RJ, Shevtsova EI, Belyakin S, Yurlova AA, Osofsky SA, Miquelle DG, Matthews L, Cleaveland S]
通讯作者: Cleaveland S
DOI: 10.1371/journal.ppat.1010022
发表时间: 2021-12
期刊: PLoS pathogens
影响因子: 6.7
作者: [Davis C, Logan N, Tyson G, Orton R, Harvey WT, Perkins JS, Mollett G, Blacow RM, COVID-19 Genomics UK (COG-UK) Consortium, Peacock TP, Barclay WS, Cherepanov P, Palmarini M, Murcia PR, Patel AH, Robertson DL, Haughney J, Thomson EC, Willett BJ, COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators]
通讯作者: COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators
6
    A One Health approach to pan-valent morbillivirus vaccines
    • 批准号:
      BB/R019843/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $98.53万
    • 财政年份:
      2018
    • 负责人:
      Brian Willett
    • 依托单位:
    A viral pseudotype based approach to measuring morbillivirus neutralising antibodies
    • 批准号:
      BB/M018628/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $19.07万
    • 财政年份:
      2015
    • 负责人:
      Brian Willett
    • 依托单位:
    国内基金
    海外基金
    牛肌生成抑制素受体分子生物学特性研究
    • 批准号:
      30972108
    • 项目类别:
      面上项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2009
    • 负责人:
      吕文发
    • 依托单位:
    牛肌生成抑制素基因分子生物学研究
    • 批准号:
      30500366
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2005
    • 负责人:
      吕文发
    • 依托单位: